Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT02427113
Other study ID # ZurichUAS
Secondary ID
Status Not yet recruiting
Phase N/A
First received March 25, 2015
Last updated April 24, 2015
Start date May 2015
Est. completion date March 2016

Study information

Verified date April 2015
Source University of Toronto
Contact Allan Gordon, PhD
Phone 416-586-5181
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The purpose of the study will be to examine the effectiveness of an innovative use of music on TMD. Music and rhythmic vibrations can alter the basic processes related to sensation of pain in the brain. As well, music can block the neurological pathways that transmit pain sensations and thereby reduce pain. Music and vibrations are relaxing, reduce stress, and thereby reduce sensitivity to pain.


Description:

The investigators hypothesize that patients will experience less pain, an elevation in mood, a decrease in stress, higher well-being, and a reduction in TMD symptoms after receiving therapeutic music treatments. The investigators further predict that the vibrations generated by the Sound Oasis VTS1000 (vibroacoustic chair) will produce stronger effects than self-selected music. The question to be investigated in this study: "What are the effects of music on TMD symptoms?"

Participant intake will occur prior to study providing information on diagnostics, music preferences, participant demographics, and participant randomization. The study will consist of 4 assessments and 2 treatments with a 1 month wash-out period between treatments. Assessment 1 (will serve as pre-test) and occur before 1st treatment. Assessment 2 (will serve as post-test), taking place before 2nd treatment and will last 45 minutes. Assessment 3 will follow the wash-out period; and assessment 4 (the final session), which will be a total of 60 minutes will include a participant treatment review interview. Pre/post assessments will be utilized as a means to examine change in pain at the level of each participant, mood levels, depression and the perception of quality of life.

Therapeutic music treatments, which will consist of randomly assigned interventions of Sound Oasis VTS-1000 and preferred music playlist, will be prescribed for self-administered in-home sessions for 3-weeks, 7 days (recommended) but at least a minimum of 5 days per week. During each 3-week music treatment period, 1 self-administered in-home music treatment will be prescribed for 3-weeks, 7 days (recommended) but at least a minimum of 5 days per week.

There will be 2 times where the participants receive no therapeutic music intervention but will continue with treatment as usual which will occur 7 days prior to each treatment. Participants will be asked to do a daily pain rating for one week during treatment as usual before the start of the music interventions.

There will be a 4-week wash-out period between therapeutic music treatments 1 and 2. There will be no music treatment during this time. Participants will be asked to keep a record of the type of medication taken, a pill count, and frequency of medication during this time as well as during treatment.

Both therapeutic music and treatment as usual times will be intervened by a treatment compliance email or phone call by the music therapist. Participants will be randomly assigned to 2 groups: (a) Sound Oasis VTS-1000 and (b) participant preferred music. Participants will complete questionnaires at the beginning of the study, following the end of the first 3 weeks of either therapeutic music treatment, at the end of the second 3 weeks of therapeutic music and during the final assessment time, which will also consist of a brief interview about treatment received.

Data will be analyzed with reference given only to an assigned ID number. All information collected will be used for this study to investigate the effects of therapeutic music on the management of TMD symptoms. Furthermore, all participants will be informed that all information that will be disclosed will remain confidential, unless the disclosed information will cause harm to self or others.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 24
Est. completion date March 2016
Est. primary completion date December 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 20 Years and older
Eligibility Inclusion Criteria:

- hearing able as listening to music is required as part of treatment

- main source of pain is myofascial pain

- on-going pain for 6 months

Exclusion Criteria:

- Acute Inflammatory Conditions - an inflammation having a rapid onset, with a clear and distinct termination. (e.g. Rheumatoid arthritis and Osteoarthritis)

- Clients Presenting with Psychoses

- Pregnancy

- Hemorrhaging or Active Bleeding

- Thrombosis

- Hypotension

- Pacemakers as contraindications of Vibroacoustic Therapy (VAT) are related to these conditions.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Temporomandibular Joint Disorders
  • Temporomandibular Joint Dysfunction Syndrome
  • TMD

Intervention

Other:
Sound Oasis Vibrating Chair
Sound oasis vibroacoustic chair will be used as treatment for managing TMD related pain
Self-Select Music
The self-select music of the participants will be applied for managing the painful symptoms of TMD

Locations

Country Name City State
n/a

Sponsors (2)

Lead Sponsor Collaborator
University of Toronto Mount Sinai Hospital, Canada

Outcome

Type Measure Description Time frame Safety issue
Other Mult-Dimensional Mood Questionnaire 3 months No
Other Quality of Life Enjoyment and Satisfaction Questionnaire 3 months No
Primary Visual Analog Scale to measure pain levels A psychometric response scale which can be used in questionnaires to measure participants pain levels. 3 months No
Secondary Short Inventory Depression Scale 3 months No
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Not yet recruiting NCT04326608 - Psycho-social Aspects After a Physiotherapy Intervention in Chronic TMD Pain
Enrolling by invitation NCT05676827 - Pain, Central Sensitization and Psychoemotional State in Patients With Chronic Masticatory Muscle Pain
Completed NCT02946645 - Efficiency of Neuromuscular Bite vs Physiotherapy in TMD Patients N/A
Completed NCT03398486 - The Effectiveness of Kinesiotaping and Inactivation of Trigger Points in Chronic Myofascial Pain of TMD N/A
Terminated NCT03522207 - Accuracy and Efficacy of Trazodone (Desyrel) on Sleep Quality and Pain Management of TMD Patient Phase 4
Completed NCT04241562 - Validation of a Novel Cortical Biomarker Signature for Pain
Recruiting NCT05620758 - Laser Therapy and Temporomandibular Disorders N/A
Recruiting NCT01659372 - Low Level Laser Therapy Versus Pharmacotherapy in in Improving Masticatory Muscle Pain Phase 1
Completed NCT05660343 - Ozonated Olive Oil and Low-Level Laser Therapy in TMD Treatment N/A
Recruiting NCT04543981 - Prevalence of the Signs and Symptoms of TMD in Adolescents
Recruiting NCT06339736 - Treatment Outcomes in Patients With Muscular Temporo-mandibular Joint Disorders
Completed NCT05955222 - Clinical Performance of CAD/CAM Splint Materials N/A
Completed NCT05288647 - Computer Guided Versus Conventional TMJ Injection N/A
Completed NCT04409067 - Masticatory Muscle Activity in Patients With Pain-related Temporomandibular Disorders
Completed NCT05302466 - Additive Effects of Dental Bite Pads During Gymnastic Exercises for the Relief of Chronic Non-specific Neck Pain in Working Women and Men at a VDU Workplace N/A
Recruiting NCT04618445 - Prevalence of Temporomandibular Joint Disorders Among Egyptian University Undergraduate Students
Completed NCT04298554 - Comparison of Cannabinoids to Placebo in Management of TMJ Pain and Myofascial Pain in the TMJ Region N/A
Recruiting NCT05003349 - Pain Neuroscience Education, Motor Imagery and Action Observation in Patients With Chronic Temporomandibular Disorders. N/A
Completed NCT05522114 - Accuracy of Patient Specific Guide for TMJ Injection N/A